vs
Emerald Holding, Inc.（EEX）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是Emerald Holding, Inc.的1.5倍（$197.9M vs $132.7M），REPLIGEN CORP净利率更高（6.7% vs -22.8%，领先29.5%），Emerald Holding, Inc.同比增速更快（24.3% vs 13.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $11.7M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -0.3%）
TVS Emerald Haven地产有限公司是一家印度房地产开发企业，总部位于泰米尔纳德邦金奈，为TVS控股旗下子公司，专注于打造可持续居住社区以及各类城市开发项目，在印度本土房地产业务领域拥有清晰的业务定位。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
EEX vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.5倍
$132.7M
营收增速更快
EEX
高出10.6%
13.6%
净利率更高
RGEN
高出29.5%
-22.8%
自由现金流更多
RGEN
多$5.9M
$11.7M
两年增速更快
RGEN
近两年复合增速
-0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $132.7M | $197.9M |
| 净利润 | $-30.2M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | -11.8% | 9.0% |
| 净利率 | -22.8% | 6.7% |
| 营收同比 | 24.3% | 13.6% |
| 净利润同比 | -692.2% | 143.9% |
| 每股收益（稀释后） | $-0.15 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EEXRGEN
| Q4 25 | $132.7M | $197.9M | ||
| Q3 25 | $77.5M | $188.8M | ||
| Q2 25 | $105.5M | $182.4M | ||
| Q1 25 | $147.7M | $169.2M | ||
| Q4 24 | $106.8M | $174.1M | ||
| Q3 24 | $72.6M | $154.9M | ||
| Q2 24 | $86.0M | $154.1M | ||
| Q1 24 | $133.4M | $151.3M |
净利润EEXRGEN
| Q4 25 | $-30.2M | $13.3M | ||
| Q3 25 | $-14.4M | $14.9M | ||
| Q2 25 | $-1.4M | $14.9M | ||
| Q1 25 | $15.3M | $5.8M | ||
| Q4 24 | $5.1M | $-30.3M | ||
| Q3 24 | $-11.1M | $-654.0K | ||
| Q2 24 | $-2.8M | $3.3M | ||
| Q1 24 | $11.0M | $2.1M |
毛利率EEXRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率EEXRGEN
| Q4 25 | -11.8% | 9.0% | ||
| Q3 25 | -10.1% | 8.9% | ||
| Q2 25 | 9.7% | 7.6% | ||
| Q1 25 | 24.2% | 3.9% | ||
| Q4 24 | 19.5% | -17.7% | ||
| Q3 24 | -6.5% | -5.1% | ||
| Q2 24 | 7.4% | 1.0% | ||
| Q1 24 | 18.2% | 1.3% |
净利率EEXRGEN
| Q4 25 | -22.8% | 6.7% | ||
| Q3 25 | -18.6% | 7.9% | ||
| Q2 25 | -1.3% | 8.2% | ||
| Q1 25 | 10.4% | 3.4% | ||
| Q4 24 | 4.8% | -17.4% | ||
| Q3 24 | -15.3% | -0.4% | ||
| Q2 24 | -3.3% | 2.2% | ||
| Q1 24 | 8.2% | 1.4% |
每股收益（稀释后）EEXRGEN
| Q4 25 | $-0.15 | $0.24 | ||
| Q3 25 | $-0.07 | $0.26 | ||
| Q2 25 | $-0.01 | $0.26 | ||
| Q1 25 | $0.08 | $0.10 | ||
| Q4 24 | $0.01 | $-0.55 | ||
| Q3 24 | $-0.05 | $-0.01 | ||
| Q2 24 | $-0.03 | $0.06 | ||
| Q1 24 | $0.00 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $100.9M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $338.8M | $2.1B |
| 总资产 | $1.2B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资EEXRGEN
| Q4 25 | $100.9M | $767.6M | ||
| Q3 25 | $95.4M | $748.7M | ||
| Q2 25 | $156.4M | $708.9M | ||
| Q1 25 | $276.8M | $697.2M | ||
| Q4 24 | $194.8M | $757.4M | ||
| Q3 24 | $188.9M | $784.0M | ||
| Q2 24 | $193.2M | $809.1M | ||
| Q1 24 | $186.8M | $780.6M |
总债务EEXRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益EEXRGEN
| Q4 25 | $338.8M | $2.1B | ||
| Q3 25 | $369.5M | $2.1B | ||
| Q2 25 | $389.4M | $2.1B | ||
| Q1 25 | $392.1M | $2.0B | ||
| Q4 24 | $385.9M | $2.0B | ||
| Q3 24 | $391.1M | $2.0B | ||
| Q2 24 | $407.6M | $2.0B | ||
| Q1 24 | $-90.7M | $2.0B |
总资产EEXRGEN
| Q4 25 | $1.2B | $2.9B | ||
| Q3 25 | $1.2B | $2.9B | ||
| Q2 25 | $1.2B | $2.9B | ||
| Q1 25 | $1.2B | $2.9B | ||
| Q4 24 | $1.0B | $2.8B | ||
| Q3 24 | $1.1B | $2.8B | ||
| Q2 24 | $1.1B | $2.9B | ||
| Q1 24 | $1.1B | $2.8B |
负债/权益比EEXRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $11.7M | $17.6M |
| 自由现金流率自由现金流/营收 | 8.8% | 8.9% |
| 资本支出强度资本支出/营收 | 0.5% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $41.4M | $93.9M |
8季度趋势，按日历期对齐
经营现金流EEXRGEN
| Q4 25 | $12.3M | $25.7M | ||
| Q3 25 | $1.8M | $48.1M | ||
| Q2 25 | $15.9M | $28.6M | ||
| Q1 25 | $12.6M | $15.0M | ||
| Q4 24 | $20.6M | $39.2M | ||
| Q3 24 | $9.1M | $49.3M | ||
| Q2 24 | $9.8M | $42.2M | ||
| Q1 24 | $7.3M | $44.7M |
自由现金流EEXRGEN
| Q4 25 | $11.7M | $17.6M | ||
| Q3 25 | $1.5M | $43.4M | ||
| Q2 25 | $15.8M | $21.5M | ||
| Q1 25 | $12.4M | $11.4M | ||
| Q4 24 | $19.9M | $33.6M | ||
| Q3 24 | $9.0M | $42.3M | ||
| Q2 24 | $9.6M | $37.4M | ||
| Q1 24 | $7.0M | $36.4M |
自由现金流率EEXRGEN
| Q4 25 | 8.8% | 8.9% | ||
| Q3 25 | 1.9% | 23.0% | ||
| Q2 25 | 15.0% | 11.8% | ||
| Q1 25 | 8.4% | 6.8% | ||
| Q4 24 | 18.6% | 19.3% | ||
| Q3 24 | 12.4% | 27.3% | ||
| Q2 24 | 11.2% | 24.3% | ||
| Q1 24 | 5.2% | 24.0% |
资本支出强度EEXRGEN
| Q4 25 | 0.5% | 4.1% | ||
| Q3 25 | 0.4% | 2.5% | ||
| Q2 25 | 0.1% | 3.9% | ||
| Q1 25 | 0.1% | 2.1% | ||
| Q4 24 | 0.7% | 3.2% | ||
| Q3 24 | 0.1% | 4.5% | ||
| Q2 24 | 0.2% | 3.1% | ||
| Q1 24 | 0.2% | 5.5% |
现金转化率EEXRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | 0.82× | 2.57× | ||
| Q4 24 | 4.04× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | 0.66× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EEX
| Connections Segment | $121.9M | 92% |
| Commerce Segment | $5.5M | 4% |
| Content | $5.3M | 4% |
RGEN
暂无分部数据
